Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer, Cancer spread to the brain, Lung cancer, Secondary cancers
Closed
Phase 1/2
This trial is looking at whether a single dose of radiotherapy improves the way afatanib works on cancer that has spread to the brain. It is for people with breast cancer or lung cancer that has spread to the brain and who can have surgery to remove the cancer. This trial is supported by Cancer Research UK.
Recruitment start: 26 February 2015
Recruitment end: 12 August 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Richard Baird
Cancer Research UK
Cambridge University Hospitals NHS Foundation Trust
University of Cambridge
Experimental Cancer Medicine Centre
The Brain Tumour Charity
Boehringer-Ingelheim
NCRI Radiotherapy Trials QA Group (RTTQA)
This is Cancer Research UK trial number CRUK/12/047.
Last reviewed: 7 October 2020
CRUK internal database number: 10561
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
